Zobrazeno 1 - 10
of 143
pro vyhledávání: '"P. S. Schein"'
Publikováno v:
Anais do Congresso Brasileiro de Engenharia Química em Iniciação Científica - Cobeq IC 2015.
RESUMO – A producao de micro/nanoparticulas tem atraido interesse de inumeras pesquisas, uma vez que o desenvolvimento tecnologico possibilitou a producao e manipulacao das mesmas, tendo aplicacao em diversas areas, como pigmentos, polimeros, farma
Publikováno v:
Cancer Investigation. 9:279-287
WR-2721 is a unique bone marrow protective agent which also protects other normal tissues against the toxic effects of radiation therapy and chemotherapy, especially with cisplatin and alkylating agents. In addition to protection against acute toxici
Autor:
P J, Cagnoni, R B, Jones, S I, Bearman, M, Ross, L, Hami, W A, Franklin, R, Capizzi, P S, Schein, E J, Shpall
Publikováno v:
Seminars in oncology. 23(4 Suppl 8)
One of the main obstacles for the use of high-dose chemotherapy with autologous hematopoietic progenitor cell support in the treatment of malignancies is the possibility of reinfusing clonogenic tumor cells with the hematopoietic graft. Purging of th
Publikováno v:
Cancer. 72
Amifostine (US Bioscience, West Conshohocken, PA; Ethyol, WR-2721), a phosphorylated thiol developed by the United States Army as a protective agent for military personnel in the event of nuclear warfare, has shown protection of normal tissues from t
Publikováno v:
Anti-cancer drug design. 5(4)
A series of new water soluble sugar and non-sugar containing platinum(II) complexes was synthesized and evaluated for effects of the sugar moiety on water solubility, anti-tumor activity, and acute leukopenia. When tested in vivo against the murine P
Autor:
Judith M Bliss, H Cortes-Funes, Jacques Wils, G Beretta, R C Coombes, C E D Chilvers, D Amadori, A Villar-Grimalt, P S Schein, A Rutten
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 8(8)
Three hundred fifteen patients with operable gastric cancer were randomized to receive fluorouracil, Adriamycin (doxorubicin; Adria Laboratories, Columbus, OH), and mitomycin (FAM) or no adjuvant treatment between September 1981 and July 1984. After
Publikováno v:
Experimental Biology and Medicine. 151:632-635
SummaryHypoglycemic rats bearing insulin-secreting islet-cell adenomas produced by the combined action of streptozotocin and nicotinamide were treated with streptozotocin. Antitumor response was demonstrated by elevation of blood glucose, reduction i
Autor:
P S Schein
Publikováno v:
Journal of Clinical Oncology. 2:1433-1439
Publikováno v:
Endocrinology. 89:827-834
Intravenous streptozotocin, 50 mg/kg, caused a marked rise in blood glucose, FFA and ketone bodies 3 hr after administration to 48-hr starved rats. At 7 hr the animals were hypoglycemic with falls in blood ketone bodies and FFA and a rise in blood py
Autor:
P. S. Schein
Publikováno v:
Archives of Dermatology. 105:244-246